Evidence map›Paper›PMID 28332006›Full record

ArticlePsychopharmacology2017

Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice.

Tursun Alkam, Takayoshi Mamiya, Nami Kimura, Aya Yoshida, Daisuke Kihara, Yuki Tsunoda, Yuki Aoyama, Masayuki Hiramatsu, Hyoung-Chun Kim, Toshitaka Nabeshima

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Nicotine on the developing brain.Pharmacological research · 2023
    Review
  7. Review
  8. Review
  9. Nicotine and the developing brain: Insights from preclinical models.Pharmacology, biochemistry, and behavior · 2022
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Tursun AlkamDepartment of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Takayoshi MamiyaDepartment of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Nami KimuraDepartment of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Aya YoshidaDepartment of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Daisuke KiharaDepartment of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Yuki TsunodaDepartment of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Yuki AoyamaDepartment of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Masayuki HiramatsuDepartment of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Hyoung-Chun KimNeuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chunchon, South Korea.
Toshitaka NabeshimaDepartment of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan. tnabeshi@ccalumni.meijo-u.ac.jp.
Meijo University · JPKangwon National University · KRWestern University of Health Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased risk of attention-deficit/hyperactivity disorder (AD/HD) is partly associated with the early developmental exposure to nicotine in tobacco smoke. Emerging reports link tobacco smoke exposure or prenatal nicotine exposure (PNE) with AD/HD-like behaviors in rodent models. We have previously reported that PNE induces cognitive behavioral deficits in offspring and decreases the contents of dopamine (DA) and its turnover in the prefrontal cortex (PFC) of offspring It is well known that the dysfunction of DAergic system in the brain is one of the core factors in the pathophysiology of AD/HD. Therefore, we examined whether the effects of PNE on the DAergic system underlie the AD/HD-related behavioral changes in mouse offspring. PNE reduced the release of DA in the medial PFC (mPFC) in mouse offspring. PNE reduced the number of tyrosine hydroxylase (TH)-positive varicosities in the mPFC and in the core as well as the shell of nucleus accumbens, but not in the striatum. PNE also induced behavioral deficits in cliff avoidance, object-based attention, and sensorimotor gating in offspring. These behavioral deficits were attenuated by acute treatment with atomoxetine (3 mg/kg, s.c.) or partially attenuated by acute treatment with MPH (1 mg/kg, s.c.). Taken together, our findings support the notion that PNE induces neurobehavioral abnormalities in mouse offspring by disrupting the DAergic system and improve our understanding about the incidence of AD/HD in children whose mothers were exposed to nicotine during their pregnancy.

Indexed as

Adrenergic Uptake InhibitorsAnimalsAtomoxetine HydrochlorideAttention Deficit Disorder with HyperactivityCognition DisordersDopamineFemaleMaleMiceMice, Inbred C57BLNicotinePrefrontal CortexPregnancyPrenatal Exposure Delayed EffectsAdrenergic Uptake InhibitorsAtomoxetine HydrochlorideDopamineNicotineAtomoxetineCliff avoidanceDopamineObject-based attentionPrenatal nicotine exposure

Identifiers

PMID28332006
OpenAlexW2597499553

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.